glp-1 cancer prevention Could medications help slow progression?⁣ ⁣ A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to Could GLP-1 Drugs Reduce Obesity-Related

No significant difference in outcomes was seen between the 10 mg and 25 mg empagliflozin doses

In a Phase III trial of 886 patients, Keytruda, a PD-1 inhibitor, plus Padcev, an antibody-drug conjugate, reduced the risk of death by 53% over platinum-based chemotherapy

No chugging thick shakes

The experience of infertility: a review of recent literature

GLP-1 receptor agonists also reduced the risk of cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and all-cause mortality, with high-certainty evidence

Heres an exploration of key peptides being studied for their effects on sleep: CJC-1295/Ipamorelin CJC-1295/Ipamorelin are synthetic growth hormone-releasing peptides (GHRPs) designed to enhance the bodys natural production of growth hormone (GH)